PROMM and deafness: Exclusion of ZNF9 as the disease gene in DFNA18 suggests a polygenic origin of the PROMM/DM2 phenotype [2]

Clinical Genetics

Volumn 63, Issue 1, 2003, Pages 73-75

  Bönsch, Dominikus ^a   Neumann, C ^b   Lang Roth, R ^b   Witte, O ^b   Lamprecht Dinnesen, A ^b   Deufel, T ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZINC FINGER PROTEIN; MYOTONIC DYSTROPHY PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RNA BINDING PROTEIN; ZNF9 PROTEIN, HUMAN;

ALLELE; CATARACT; CHROMOSOME 3Q; CHROMOSOME MAP; CLINICAL FEATURE; EXON; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEARING IMPAIRMENT; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INTRON; LETTER; MUSCLE WEAKNESS; MYOTONIA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR DYSTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CHROMOSOME 3; GENETICS;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; DEAFNESS; HUMANS; MYOTONIC DISORDERS; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS;

EID: 0038078537     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.630112.x     Document Type: Letter

References (20)

1. Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy - a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 1997: 7: 217-228.
2. Wright RB, Glantz RH, Butcher J. Hearing loss in myotonic dystrophy. Ann Neurol 1988: 23: 202-203.
3. Bönsch D, Scheer P, Neumann C et al. A novel locus for autosomal dominant, non-syndromic hearing impairment (DFNA18) maps to chromosome 3q22 immediately adjacent to the DM2 locus. Eur J Hum Genet 2001: 9: 165-170.
4. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW, Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998: 19: 196-198.
5. Liquori CL, Ricker K, Moseley ML et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001: 293: 864-867.
6. Rajavashisth TB, Taylor AK, Andalibi A, Svenson KL, Lusis AJ. Identification of a zinc finger protein that binds to the sterol regulatory element. Science 1989: 245: 640-643.
7. Flink IL, Morkin E. Alternatively processed isoforms of cellular nucleic acid-binding protein interact with a suppressor region of the human beta-myosin heavy chain gene. J Biol Chem 1995: 270: 6959-6965.
8. De Dominicis A, Lotti F, Pierandrei-Amaldi P, Cardinali B. cDNA cloning and developmental expression of cellular nucleic acid-binding protein (CNBP) gene in Xenopus laevis. Gene 2000: 241: 35-43.
9. Flink IL, Morkin E. Organization of the gene encoding cellular nucleic acid-binding protein. Gene 1995: 163: 279-282.
10. Groenen P, Wieringa B. Expanding complexity in myotonic dystrophy. Bioessays 1998: 20: 901-912.
11. Korade-Mirnics Z, Babitzke P, Hoffman E. Myotonic dystrophy: molecular windows on a complex etiology. Nucl Acids Res 1998: 26: 1363-1368.
12. Wang J, Pegoraro E, Menegazzo E et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 1995: 4: 599-606.
13. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998: 280: 737-741.
14. Timchenko LT, Miller JW, Timchenko NA et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucl Acids Res 1996: 24: 4407-4414.
15. Tian B, White RJ, Xia T et al. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 2000: 6: 79-87.
16. Mankodi A, Logigian E, Callahan L et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000: 289: 1769-1773.
17. Winchester CL, Ferrier RK, Sermoni A, Clark BJ, Johnson KJ. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet 1999: 8: 481-492.
18. Kramer PL, LaMorticella D, Schilling K, Biilingslea AM, Weleber RG, Litt M. A new locus for autosomal dominant congenital cataracts maps to chromosome 3. Invest Ophthalmol Visual Sci 2000: 41: 36-39.
19. Jakobs PM, Hess JF, FitzGerald PG, Kramer PL, Weleber RG, Litt M. Autosomal-dominant congenital cataract associated with a deletion mutation in the human beaded filament protein gene BFSP2. Am J Hum Genet 2000: 66: 1432-1436.
20. Carter JM, McLean WHI, West S, Quinlan RA. Mapping of the human CP49 gene and identification of an intragenic polymorphic marker to allow genetic linkage analysis in autosomal-dominant congenital cataract. Biochem Biophys Res Commun 2000: 270: 432-436.